Dr Reddy’s Laboratories Ltd ADR
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $86,594,047 | $81,183,773 | $76,331,392 | $87,268,000 |
Gross Profit | 45,144,592 | 37,762,702 | 34,215,174 | 46,806,000 |
EBITDA | 17,140,444 | 8,343,524 | 8,758,174 | 19,722,000 |
EBIT | 11,878,369 | 2,971,524 | 3,095,421 | 14,509,000 |
Net Income | 9,237,843 | 4,461,310 | 2,235,244 | 12,098,000 |
Net Change In Cash | 86,594,047 | 81,183,773 | 76,331,392 | 87,268,000 |
Free Cash Flow | 2,305,624 | -4,629,000 | 10,748,982 | 3,588,000 |
Cash | 13,352,266 | 11,204,000 | 15,063,755 | 18,657,000 |
Basic Shares | 833,333 | 832,671 | 834,805 | 833,196 |
Annual Financials
| Values in thousands | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
Revenue | $353,471,642 | $325,535,000 | $279,164,000 | $245,879,000 |
Gross Profit | 186,518,732 | 190,428,000 | 163,607,000 | 139,343,000 |
EBITDA | 83,293,896 | 96,671,000 | 88,422,000 | 74,431,000 |
EBIT | 61,612,083 | 79,613,000 | 73,581,000 | 61,795,000 |
Net Income | 45,087,145 | 56,544,000 | 55,684,000 | 45,067,000 |
Net Change In Cash | 353,471,642 | 325,535,000 | 279,164,000 | 245,879,000 |
Free Cash Flow | 32,101,837 | 12,030,000 | 17,998,000 | 40,009,000 |
Cash | 15,063,755 | 14,654,000 | 7,107,000 | 5,779,000 |
Basic Shares | 833,263 | 834,298 | 833,537 | 831,912 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | $0.12 |
2026-06-30 | $0.06 |
2026-03-31 | $0.02 |
2025-12-31 | $0.16 |